© 2001 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
Plasma Acylation Stimulating Protein Concentration and Subcutaneous Adipose Tissue C3 mRNA Expression in Nondiabetic and Type 2 Diabetic Men
From the Department of Medicine (H.A.K., V.A.K., P.E.), Division of Geriatrics, and the Department of Clinical Chemistry (S.-L.K.), Helsinki University Central Hospital, Helsinki, Finland, and INSERM U449 (H.V., E.D., P.V.), Faculté de Médecine R.T.H. Laennec, Lyon, France. V.A.K. is currently at Eli Lilly Research Laboratories, Hamburg, Germany.
Correspondence to Dr Heikki Koistinen, Karolinska Institutet, Integrativ fysiologi, von Eulers väg 4, 2 TR, 17 177 Stockholm, Sweden. E-mail heikki_koistinen{at}yahoo.com
Abstract—We studied the effect of an oral fat load on plasma acylation stimulating protein (ASP) concentrations in 9 lean healthy (age 59±2 years, body mass index [BMI] 23.2±0.4 kg/m2; both mean±SEM), 9 obese nondiabetic (58±2 years, BMI 29.4±0.5 kg/m2), and 12 type 2 diabetic (60±2 years, BMI 29.6±1.0 kg/m2) men. Because ASP is a cleavage product of complement protein C3 (C3adesArg) and its secretion is regulated by insulin, we also examined the subcutaneous adipose tissue expression of C3 mRNA before and after a 240-minute euglycemic hyperinsulinemic clamp in a subgroup of these men. Plasma ASP concentration and adipose tissue C3 mRNA expression were higher in the obese groups than in the lean men. Plasma ASP concentration did not change significantly after the fat load. Fasting plasma ASP concentration and C3 mRNA expression were correlated negatively with insulin sensitivity and positively with the magnitude of postprandial lipemia in nondiabetic but not in type 2 diabetic men. The expression of C3 mRNA was not regulated by insulin. These data suggest that ASP is associated with whole-body glucose and lipid metabolism in nondiabetic individuals, whereas metabolic disturbances in diabetes may overcome the regulatory role of ASP in lipid and glucose metabolism.
Key Words: acylation stimulating protein (ASP) • insulin resistance • obesity • postprandial lipemia • RT competitive PCR
This article has been cited by other articles:
 |
|
 |
|
  W. Cui, S. Paglialunga, D. Kalant, H. Lu, C. Roy, M. Laplante, Y. Deshaies, and K. Cianflone Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1482 - E1491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Faraj, G. Beauregard, E. Loizon, M. Moldes, K. Clement, Y. Tahiri, K. Cianflone, H. Vidal, and R. Rabasa-Lhoret Insulin regulation of gene expression and concentrations of white adipose tissue-derived proteins in vivo in healthy men: relation to adiponutrin. J. Endocrinol., November 1, 2006; 191(2): 427 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Warnberg, E. Nova, L. A Moreno, J. Romeo, M. I Mesana, J. R Ruiz, F. B Ortega, M. Sjostrom, M. Bueno, A. Marcos, et al. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am. J. Clinical Nutrition, September 1, 2006; 84(3): 505 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Wernstedt, B. Olsson, M. Jernas, S. Paglialunga, L. M. S. Carlsson, U. Smith, K. Cianflone, K. Wallenius, and V. Wallenius Increased Levels of Acylation-Stimulating Protein in Interleukin-6-Deficient (IL-6-/-) Mice Endocrinology, June 1, 2006; 147(6): 2690 - 2695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Yu and H. N. Ginsberg Adipocyte Signaling and Lipid Homeostasis: Sequelae of Insulin-Resistant Adipose Tissue Circ. Res., May 27, 2005; 96(10): 1042 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Engstrom, B. Hedblad, K.-F. Eriksson, L. Janzon, and F. Lindgarde Complement C3 Is a Risk Factor for the Development of Diabetes: A Population-Based Cohort Study Diabetes, February 1, 2005; 54(2): 570 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Karelis, D. H. St-Pierre, F. Conus, R. Rabasa-Lhoret, and E. T. Poehlman Metabolic and Body Composition Factors in Subgroups of Obesity: What Do We Know? J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2569 - 2575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J van Oostrom, H. van Dijk, C. Verseyden, A. D Sniderman, K. Cianflone, T. J Rabelink, and M. Castro Cabezas Addition of glucose to an oral fat load reduces postprandial free fatty acids and prevents the postprandial increase in complement component 3 Am. J. Clinical Nutrition, March 1, 2004; 79(3): 510 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Havel Update on Adipocyte Hormones: Regulation of Energy Balance and Carbohydrate/Lipid Metabolism Diabetes, February 1, 2004; 53(90001): S143 - 151. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Cianflone, R. Zakarian, C. Couillard, B. Delplanque, J.-P. Despres, and A. Sniderman Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance J. Lipid Res., January 1, 2004; 45(1): 124 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Faraj, P. J. Havel, S. Phelis, D. Blank, A. D. Sniderman, and K. Cianflone Plasma Acylation-Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese Subjects J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1594 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Meijssen, H. van Dijk, C. Verseyden, D.W. Erkelens, and M. C. Cabezas Delayed and Exaggerated Postprandial Complement Component 3 Response in Familial Combined Hyperlipidemia Arterioscler. Thromb. Vasc. Biol., May 1, 2002; 22(5): 811 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ozata, C. Oktenli, M. Gulec, T. Ozgurtas, F. Bulucu, K. Caglar, N. Bingol, A. Vural, and I. C. Ozdemir Increased Fasting Plasma Acylation-Stimulating Protein Concentrations in Nephrotic Syndrome J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 853 - 858. [Abstract] [Full Text] [PDF]
|
|